Philip P. Vella
- Microbiology top 1%
- Bacterial Infections and Vaccines 16
- Epidemiology top 5%
- Pneumonia and Respiratory Infections 20
- Respiratory viral infections research 5
- Influenza Virus Research Studies 2
-
- Immunodeficiency and Autoimmune Disorders 6
- Gastroenterology top 10%
-
- Monoclonal and Polyclonal Antibodies Research 11
- Radiopharmaceutical Chemistry and Applications 1
-
- Peptidase Inhibition and Analysis 2
- Co-authors
- A. A. McLeanA. F. WoodhourM. R. HillemanRobert E. WeibelJ. M. BorgoñoRonald W. EllisPeter J. KniskernStephen Marburg
- Cited by
- MicrobiologyEpidemiologyImmunology
- Journals
- Journal of the American Chemical Society (1 paper)PEDIATRICS (3 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesGambiaFinland
In The Last Decade
Philip P. Vella
26 papers receiving 915 citations
Peers
Comparison fields: 5 of 69
- Microbiology 467
- Epidemiology 818
- Immunology 184
- Gastroenterology 37
- Radiology, Nuclear Medicine and Imaging 145
Countries citing papers authored by Philip P. Vella
This map shows the geographic impact of Philip P. Vella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip P. Vella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip P. Vella more than expected).
Fields of papers citing papers by Philip P. Vella
This network shows the impact of papers produced by Philip P. Vella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip P. Vella. The network helps show where Philip P. Vella may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip P. Vella, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 27 | |
| 2 | 1993 | 14 | |
| 3 | 1993 | 8 | |
| 4 | 1993 | 49 | |
| 5 | 1992 | 46 | |
| 6 | 1992 | 11 | |
| 7 | 1991 | 3 | |
| 8 | 1991 | 29 | |
| 9 | 1991 | 2 | |
| 10 | Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation. | 1990 | 39 |
| 11 | 1990 | 31 | |
| 12 | 1990 | 25 | |
| 13 | 1988 | 42 | |
| 14 | 1981 | 107 | |
| 15 | 1980 | 39 | |
| 16 | 1979 | 18 | |
| 17 | Polyvalent pneumococcal polysaccharide vaccines. | 1978 | 25 |
| 18 | 1977 | 75 | |
| 19 | 1976 | 12 | |
| 20 | 1965 | 9 |
About Philip P. Vella
Philip P. Vella is a scholar working on Microbiology, Epidemiology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (20 papers), Bacterial Infections and Vaccines (16 papers), Monoclonal and Polyclonal Antibodies Research (11 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Respiratory viral infections research (5 papers), Influenza Virus Research Studies (2 papers), Peptidase Inhibition and Analysis (2 papers) and Radiopharmaceutical Chemistry and Applications (1 paper). The work is most often cited by research in Microbiology (467 citations), Epidemiology (818 citations) and Immunology (184 citations). Philip P. Vella has collaborated with scholars based in United States, Gambia and Finland. Frequent co-authors include A. A. McLean, A. F. Woodhour, M. R. Hilleman, Robert E. Weibel, J. M. Borgoño, Ronald W. Ellis, Peter J. Kniskern, Stephen Marburg, Richard L. Tolman and C M Rusk. Their work appears in journals such as Journal of the American Chemical Society, PEDIATRICS and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.